Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation

Published:2004-11 Issue:11 Volume:10 Page:805-812
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Tran Hai,Petropoulos Demetrios,Worth Laura,Mullen Craig A.,Madden Timothy,Andersson Borje,Choroszy Mary,Nguyen John,Webb Susannah K.,Chan Ka Wah

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference30 articles.

1. Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease;Andersson;Biol Blood Bone Marrow Transplant.,2002

2. Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation;McCune;Bone Marrow Transplant.,2002

3. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation;Vassal;Cancer Chemother Pharmacol.,1996

4. Population pharmacokinetics of oral busulfan in children;Schiltmeyer;Cancer Chemother Pharmacol.,2003

5. Age-dependent tetrahydrothiophenium ion formation in young children and adults receiving high-dose busulfan;Gibbs;Cancer Res.,1997

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose individualization of intravenous busulfan in pediatric patients undergoing bone marrow transplantation: impact and in vitro evaluation of infusion lag-time;Journal of Pharmacy and Pharmacology;2021-07-09

2. Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy;Biology of Blood and Marrow Transplantation;2020-10

3. Busulfan clearance does not predict the development of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation;International Journal of Hematology;2020-05-28

4. Pharmacokinetic analysis for model‐supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients;Pediatric Transplantation;2020-03-20

5. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children;Therapeutic Drug Monitoring;2020-02